Attached files

file filename
EX-32.2 - EX-32.2 - INCYTE CORPincy-20161231ex322c73587.htm
EX-32.1 - EX-32.1 - INCYTE CORPincy-20161231ex3217753b0.htm
EX-31.2 - EX-31.2 - INCYTE CORPincy-20161231ex312b86f7d.htm
EX-31.1 - EX-31.1 - INCYTE CORPincy-20161231ex311539c5f.htm
EX-23.1 - EX-23.1 - INCYTE CORPincy-20161231ex231e563b7.htm
EX-12.1 - EX-12.1 - INCYTE CORPincy-20161231ex12197ee9e.htm
EX-10.27 - EX-10.27 - INCYTE CORPincy-20161231ex10278e93b.htm
EX-10.26 - EX-10.26 - INCYTE CORPincy-20161231ex102621122.htm
EX-10.20.4 - EX-10.20.4 - INCYTE CORPincy-20161231ex10204c703.htm
10-K - 10-K - INCYTE CORPincy-20161231x10k.htm

Exhibit 21.1

SUBSIDIARIES

 

 

Subsidiary

Jurisdiction of Incorporation

Incyte Pharma UK Ltd.

United Kingdom

Incyte Holdings Corporation

Delaware

Incyte International Holdings S.à r.l.

Luxembourg

Incyte Europe S.à r.l.

Switzerland

Incyte Spain S.L.

Spain

Incyte Italy S.r.l.

Italy

Incyte Germany GmbH

Germany

Incyte Biosciences Luxembourg S.à r.l

Incyte Biosciences International S.à r.l.

Incyte Biosciences Denmark ApS

Incyte Biosciences Finland Oy

Incyte Biosciences Germany GmbH

Incyte Biosciences Benelux B.V.

Incyte Biosciences Iberia S.L.

Incyte Biosciences UK Ltd

Incyte Biosciences Austria GmbH

Incyte Biosciences Israel Ltd

Incyte Biosciences France

Incyte Biosciences Italy S.R.L.

Incyte Biosciences Norway AS

Incyte Biosciences Nordic AB

Incyte Biosciences Canada ULC

Luxembourg

Switzerland

Denmark

Finland

Germany

Netherlands

Spain

United Kingdom

Austria

Israel

France

Italy

Norway

Sweden

Canada